Importantly, oncolytic peptide LTX-315 derived from bovine LF has been reported to induce anti-pancreatic cancer immunity via the ATP11BPD-L1 axis and downregulates PD-L1 [47], as well as immunity, via the natural killer (NK) cells in breast cancer [48]. Here, CD274 is linked to familial pancreatic carcinoma.